With evidence that CCR2+/CX3CR1+ cells represent a potent T cell suppressive population and CCR2 ligands (CCL2 and CCL7) confer poor survival in human GBM, we evaluated the impact of CCL2 and CCL7 on cell migration. The gene discussed is CX3CR1; the disease is glioblastoma.